NeuroMetrix Announces Availability of Quell at Brookstone.com

WALTHAM, Mass.--(BUSINESS WIRE)--

NeuroMetrix, Inc. NURO announced today that Quell^® is now available at Brookstone.com.

"Brookstone is known for selling leading edge technology," said Shai N. Gozani, M.D., Ph.D., President and CEO of NeuroMetrix. "We are pleased to be working with Brookstone to broaden the availability of our Quell proprietary, 100% drug free technology for the relief of widespread chronic pain."

Quell is FDA cleared and designed for millions of people suffering from chronic pain. The latest version of Quell gives users the option to start, stop, and adjust therapy discreetly via their smartphone. It also enables advanced sleep tracking that provides feedback on multiple dimensions of sleep including sleep duration, quality, body position, time out of bed, and repetitive leg movements throughout the night. In addition to Brookstone.com, Quell is available at Target, select healthcare professionals and retailers, and at www.quellrelief.com.

About Brookstone

Brookstone is a nationwide specialty retailer offering an assortment of consumer products that are functional in purpose, distinctive in quality and design and not widely available from other retailers. In addition to their website, Brookstone operates more than 200 retail stores throughout the United States and Puerto Rico, primarily in premium shopping malls, lifestyle centers and the nation's busiest airports.

About NeuroMetrix

NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit www.NeuroMetrix.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160516005341/en/